
Last 4 earnings calls · through Q3 FY2026
The bull case is that AI chips keep getting more complex, so customers need more Synopsys software per design and EDA growth holds above the industry's recent single digits.
Ansys simulation opens industries and accounts Synopsys never sold into, and combined products let the sales force raise prices on the same design budgets.
In IP, management is negotiating royalties on customized blocks for hyperscalers, which would turn a licensing business into one that shares in the volume of chips shipped.
Strong cash flow and a much lighter debt load give management room to fund the road map, buy back shares and keep absorbing Ansys without new financing.
Export controls cap the China opportunity and push blocked customers toward domestic tool makers, so a slice of the market is lost permanently rather than delayed.
The bear case on IP is that missed delivery dates on key titles cost Synopsys sockets at hyperscalers, and the royalty model is still unsigned and unproven.
Outside AI, customers in automotive, industrial and consumer markets are still not starting enough new chips, so renewals rather than new demand carry that half of the business.
The Ansys integration is costing more than first outlined, and a lower gross margin mix means the profit improvement depends on cost synergies landing on schedule.
In short: EDA and Ansys demand is strong and guidance keeps rising, while IP delivery and China remain uneven.
A year ago double-digit EDA growth was a long-term goal; management now expects double-digit EDA growth for the full year 2026.
Management spent a year calling fiscal 2026 a muted, transitional year for IP; it now reports the segment growing again and expects sequential improvement each quarter.
Management guides Ansys to about $2.98 billion this year, growing double digits, with simulation demand broadening across aerospace, automotive and industrial customers.
Automotive, industrial and consumer customers are renewing tools but not starting enough new chips, so a large part of the EDA base contributes little incremental growth.
Synopsys now records Ansys channel sales on a gross basis, adding revenue and an equal amount of expense, so that portion of reported growth carries no profit.
In short: Cash flow is strong and debt has fallen sharply, while gross margin has slipped and reported profit is thin.
Free cash flow reached $2.7 billion over the last twelve months, about 29% of revenue, giving management room to fund the road map and pay down debt.
Net debt fell to $6.4 billion from $11.7 billion a year earlier after the term loans were repaid, and the board authorized up to $2 billion of share repurchases.
At the start of fiscal 2026 the workforce reduction was expected to cost about $225 million in cash; the latest guidance raises expected restructuring charges again.
Gross margin slipped to 72.6% as lower-margin hardware and acquired Ansys revenue became a bigger share of the total, which limits how fast overall profitability can improve.
In short: Synopsys tools sit on nearly every leading-edge chip, while China export controls cut off part of that market.
It is the only flow with thermal analysis built into chip design, and management expects to charge more for these add-on capabilities as contracts renew from 2027.
Synopsys won more than 95% of PCIe 7 opportunities in Q3 and its die-to-die IP business is on pace to double, which supports pricing and share in interconnect IP.
US export rules bar Synopsys from selling its most advanced tools and IP to some Chinese customers, and those customers are turning to domestic alternatives instead.
Revenue depends on a small number of large chipmakers and foundries, and problems at one major foundry customer already hurt results in fiscal 2025.